Vote-a-Rama Ends with Senate Passing Obamacare
Vote-a-Rama Ends with Senate Passing Obamacare Repeal
The Senate is already rolling back President Barack Obama’s legacy.
It passed the continuing resolution, S. Con.Res. 3, that tears away the fees, taxes and subsidies from the 201o Patient Protection and Affordable Cart Act, Obamacare, shortly after 1:25 Thursday morning, 51-to-48.
All Republicans, except for Sen. Rand Paul (R.-KY), voted for the resolution. Paul criticized the budget resolution for not addressing the federal debt and for not having a companion replacement bill. Sen. Dianne Feinstein (D.-CA), who is recovering from a scheduled medical procedure was absent from the chamber.
As senators waited for their names to be called by the clerk, Paul approached the clerk’s desk from side and whispered: “No.”
All Democrats and the two Independents who caucus with Democrats voted against the resolution.
Soon after they voted, virtually all Republicans left the floor. Among the handful staying behind were Majority Leader Mitch McConnell (R.-KY) and Majority Whip John Cornyn (R.-Texas), along with Sen. John R. Thune (R.-S.D.), Sen. Roy Blunt (R.-MO) in the front. McConnell sat quietly at his desk, but Cornyn stood tall in the well watching the votes come in.
All of the Democrats did not respond with their names were called off and they sat glumly with their armed crossed or their chins resting on their hand. When the Republicans were done, led by Minority Leader Charles E. Schumer (D.-N.Y.), each Democrat attempted to make remarks with their vote.
The presiding officer, Sen. Cory Gardner (R.-CO) repeatedly ruled the Democrats out of order: “Debate is not in order during a vote.”
If Gardner was slow to start rapping the palm-held ivory gavel, Cornyn would say in a stern voice: “Point of order.”
Just before the Democrats were done, Sen. Jeff Sessions (R.-AL) appeared on the floor to cast his vote for repeal and President-elect Donald J. Trump’s nominee to lead the Justice Department stayed on the Senate floor until the voting was complete.
After the final passage was announced, Sen. David Perdue (R.-Ga.) said he understood that there was more work to do to fix healthcare in America, but it was most important to start.
“Obamacare is collapsing under its own weight,” he said.
“Since President Obama and his Democratic Super Majority crammed this bill through Congress without one Republican vote, we’ve seen premiums and deductibles increase and choices decrease. Many Americans, like me and my wife, had their insurance plans cancelled altogether,” he said.
“The American people are fed-up and went to their polling booths in November to express their outrage,” he said.
The vote came after a seven-hour hour vote-a-rama that dismissed more than 150 amendments one after the other with only two minutes of debate allowed on each side before a 10-minute vote.
Shortly before midnight, Sen. Bernie Sanders (I.-Vt.) walked up to the four Democratic pages sitting on the steps on the side of the rostrum and asked: “Do you guys have to get up early in the morning tomorrow?”
A little later, Sen. Cory Booker (D.-N.J.) walked over to the clerk’s desk and passed out bags of M&M’s to the clerks and the pages. The pages are high school juniors and seniors, who come from all over the country to run errands for senators for one-year terms.
It was an interesting day for Booker. Earlier became the first sitting senator to testify against a sitting senator up for confirmation when he appeared before the Senate Judiciary Committee regarding the Sessions’ nomination for attorney general.
Then, sometime around 8:50 p.m., McConnell summoned Booker off the Senate floor for a meeting in the leader’s office that lasted until 9:10 p.m. Neither senator responded to questions from Breitbart News as they walked past the Ohio Clock on their way back to the Senate floor.
Going into the session there was still doubt if Republicans would hold together with the leadership’s strategy of using the budget reconciliation procedures, which could only strike the financial underpinnings of the 2010 Patient Protection and Affordable Care Act, leaving the rules and regulations in place for further action.
Five senators, led by Sen. Robert Corker (R. -Tenn.) and Sen. Robert Portman (R.-Ohio) had one amendment that had a very good chance to pass, which would have extended the date for Senate committees to start producing bills to effect the repeal before Jan. 27.
The other three senators were Sen. Susan Collins (R.-Maine), Sen. Lisa Murkowski (R.-Alaska) and Sen. William Cassidy (R.-La.).
The Corker-Portman effort would have prolonged the gestation period until March 3.
When he filed the amendment Jan. 9, Corker said he was motivated by the need to link a replacement to PPACA, along with the repeal of Obama’s healthcare reform legislation.
“Repeal and replace should take place simultaneously, and this amendment will give the incoming administration more time to outline its priorities after its chief health care official assumes office and fully reviews the tools currently at his disposal,” Corker said.
“By extending the deadline for budget reconciliation instructions until March, Congress and the incoming administration will each have additional time to get the policy right,” he said.
Sometime at or around 9 p.m., Corker and Portman announced they were pulling their amendment from the floor.
“We understand that everyone here understands the importance of doing it right,” Corker said.
After talking to the leadership, the Tennessean said, “We plan to withdraw this amendment and place our faith in the fact that we’re going to do this in a manner that works well for the American people.”
The advantage to the budget reconciliation procedures is that as a privileged motion, the resolution has 50 hours of debate and is then exempt from the routine 60-vote threshold to close debate.
Because the Republicans hold a 52-to-48 vote advantage, they have the simple majority required to pass a bill, but not the 60 votes to force a vote by ending debate.
In the GOP-controlled House, the Republican leadership has pledged to cooperate with Senate Republicans as they work through repeal.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...
Continue Reading
A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...
Continue Reading
Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...
Continue Reading
A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....
Continue Reading
Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...
Continue Reading
What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...
Continue Reading
BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...
Continue Reading
New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...
Continue Reading
New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...
Continue Reading
The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...
Continue Reading
Top 5 Most Recently Viewed Articles
Nvidia Raises Concerns Over Legislative Changes NVIDIA Corp. (NASDAQ: NVDA) has expressed significant concerns regarding proposed legislation in Congress, which aims to limit its ability to sell chips globally. This comes in the wake of a recent export agreement between President Trump and NVIDIA that allows chip sales to China. The company argues that the new legislative...
Continue Reading
Olin Corporation Offers Updated Outlook for Fourth Quarter Olin Corporation (NYSE: OLN) has provided insights regarding its performance for the fourth quarter of 2025, indicating a significant deviation from its previous expectations. The latest forecast suggests an adjusted EBITDA of nearly $67 million, a notable decrease from the earlier anticipated range of $110 to...
Continue Reading
Raising Standards in Business Process Outsourcing Innovature BPO is making headlines with the recent appointment of Thoai Nguyen as Chief Operating Officer. This strategic decision reflects the company's ambition to enhance its operational effectiveness and continue providing exceptional service in outsourcing. With a commitment to integrating AI-driven solutions,...
Continue Reading
TCL and F-Secure Forge a Strategic Partnership TCL, renowned for its innovations in display technology, has recently proclaimed a robust alliance with F-Secure, a leader in cybersecurity. This strategic collaboration was unveiled during Network X 2025 and aims to bolster the security features in TCL's products across Fixed Broadband (FBB), Fixed Wireless Access (FWA), and...
Continue Reading
Introduction to the Aromatherapy Accessory In today's fast-paced world, finding ways to unwind and relax is essential for maintaining overall well-being. What if you could enjoy the calming effects of aromatherapy while staying cool? An innovative inventor from Crown Point, Indiana, set out to create a solution that combines the benefits of aromatherapy with the...
Continue Reading